Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCoy

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosaAnthony D Kang, Kenneth P Smith, George M Eliopoulos, et al.
Chemotherapy|October 28, 2016
Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and OutcomesStephanie E Giancola, Monica V Mahoney, Michael D Hogan, et al.
Cytotherapy|January 19, 2010
Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cellsAbba C Zubair, Sunita Malik, Athena Paulsen, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral AntibioticsElizabeth B Hirsch, Paola C Zucchi, Alice Chen, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemicCatherine Li, Ryan W Chapin, Nicholas J Mercuro, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2018
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh ModelAnthony D Kang, Kenneth P Smith, Anders H Berg, et al.
Hospital Practice (1995)|September 7, 2016
Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussionJohn A Bosso, Anthony M Casapao, Jonathan Edwards, et al.
International Journal of Antimicrobial Agents|October 27, 2015
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolatesElizabeth B Hirsch, Brian R Raux, Paola C Zucchi, et al.
Chemotherapy|April 10, 2019
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsCorey C Burrelli, Eleanor K Broadbent, Alice Margulis, et al.
General Hospital Psychiatry|May 4, 2004
Description of a clinical pharmacist intervention administered to primary care patients with depressionKathleen M Bungay, David A Adler, William H Rogers, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|March 26, 2017
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosaAnthony D Kang, Kenneth P Smith, George M Eliopoulos, et al.
Chemotherapy|October 28, 2016
Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and OutcomesStephanie E Giancola, Monica V Mahoney, Michael D Hogan, et al.
Cytotherapy|January 19, 2010
Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cellsAbba C Zubair, Sunita Malik, Athena Paulsen, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2016
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral AntibioticsElizabeth B Hirsch, Paola C Zucchi, Alice Chen, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemicCatherine Li, Ryan W Chapin, Nicholas J Mercuro, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2018
Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh ModelAnthony D Kang, Kenneth P Smith, Anders H Berg, et al.
Hospital Practice (1995)|September 7, 2016
Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussionJohn A Bosso, Anthony M Casapao, Jonathan Edwards, et al.
International Journal of Antimicrobial Agents|October 27, 2015
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolatesElizabeth B Hirsch, Brian R Raux, Paola C Zucchi, et al.
Chemotherapy|April 10, 2019
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream InfectionsCorey C Burrelli, Eleanor K Broadbent, Alice Margulis, et al.
General Hospital Psychiatry|May 4, 2004
Description of a clinical pharmacist intervention administered to primary care patients with depressionKathleen M Bungay, David A Adler, William H Rogers, et al.
Pageof 4